High doses of saw palmetto don't impact serum PSA

High doses of saw palmetto don't impact serum PSA
Compared with placebo, saw palmetto, even at a dose as high as 960 mg, does not affect serum prostate-specific antigen levels in men with lower urinary tract symptoms, according to research published in the February issue of The Journal of Urology.

(HealthDay)—Compared with placebo, saw palmetto, even at a dose as high as 960 mg, does not affect serum prostate-specific antigen (PSA) levels in men with lower urinary tract symptoms, according to research published in the February issue of The Journal of Urology.

Gerald L. Andriole, M.D., of the Washington University School of Medicine in St. Louis, and colleagues conducted the randomized, placebo-controlled for Urologic Symptoms trial involving 369 men over the age of 45 with lower . Participants were randomized to placebo or escalating doses of saw palmetto (320, 640, and 960 mg for 24 weeks each). Serum PSA levels were assessed at baseline, 24, 48, and 72 weeks.

The researchers found that, during the study, similar changes in PSA were observed, with a mean change of 0.16 ± 1.08 ng/mL and 0.23 ± 0.83 ng/mL in the placebo and saw palmetto groups, respectively (P = 0.50). When the groups were stratified by baseline PSA there was no differential effect on serum PSA between the treatment arms.

"The results of this study are clinically relevant to men's health. While convincing data have established the lack of of saw palmetto in alleviating , many men continue to take this medication," the authors write. "By definitively establishing the lack of an effect on PSA by saw palmetto, even at supra-standard doses, our study confirms that clinicians need not adjust serum PSA in men taking this herbal supplement who opt to undergo such testing for prostate cancer early detection."

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Cancer: Tumors absorb sugar for mobility

1 hour ago

Cancer cells are gluttons. We have long known that they monopolize large amounts of sugar. More recently, it became clear that some tumor cells are also characterized by a series of features such as mobility or unlikeliness ...

Early hormone therapy may be safe for women's hearts

10 hours ago

(HealthDay)—Healthy women at low risk of cardiovascular disease may be able to take hormone replacement therapy soon after menopause for a short time without harming their hearts, according to a new study.

Low yield for repeat colonoscopy in some patients

11 hours ago

(HealthDay)—Repeat colonoscopies within 10 years are of little benefit to patients who had no polyps found on adequate examination; however, repeat colonoscopies do benefit patients when the baseline examination was compromised, ...

Cell's recycling center implicated in division decisions

13 hours ago

Most cells do not divide unless there is enough oxygen present to support their offspring, but certain cancer cells and other cell types circumvent this rule. Researchers at The Johns Hopkins University have now identified ...

User comments